Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.95184 | 75 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.66831 | 73 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.64341 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.71374 | 72 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.88237 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.89008 | 75 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.85188 | 75 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.7315 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.64975 | 72 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.58498 | 72 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.68701 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.76784 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.96154 | 75 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.7194 | 73 |